Pulmonary Hypertension Is Associated With Systemic Arterial Hypertension Among Patients With Normal Left Ventricular Diastolic Function

被引:11
作者
Itelman, Edward [1 ,2 ]
Segel, Michael J. [2 ,3 ]
Kuperstein, Rafael [2 ,4 ]
Feinberg, Micha [2 ,4 ]
Segev, Amit [2 ,4 ]
Segal, Gad [1 ,2 ]
Maor, Elad [2 ,4 ]
Grossman, Ehud [5 ]
机构
[1] Chaim Sheba Med Ctr, Internal Med Ward T, Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Chaim Sheba Med Ctr, Dept Pulmonol, Ramat Gan, Israel
[4] Chaim Sheba Med Ctr, Leviev Heart Ctr, Ramat Gan, Israel
[5] Chaim Sheba Med Ctr, Internal Med Wing, Ramat Gan, Israel
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2021年 / 10卷 / 24期
关键词
diastolic dysfunction; pulmonary hypertension; systemic arterial hypertension; CONVERTING ENZYME 2; EUROPEAN ASSOCIATION; RECOMMENDATIONS; ACTIVATION; FAILURE; SOCIETY; UPDATE;
D O I
10.1161/JAHA.121.023603
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The association of pulmonary and systemic arterial hypertension is believed to be mediated through hypertensive left heart disease. The purpose of the current study was to investigate whether pulmonary hypertension (PHT) is associated with systemic arterial hypertension among patients with apparently normal left ventricular diastolic function. Methods and Results Consecutive patients who had echocardiographic evaluation between 2007 and 2019 were enrolled. Patients with disease states that are known to be associated with PHT, including diastolic dysfunction, were excluded from the analysis. Estimated right ventricular systolic pressure was extracted for all patients from the echocardiographic reports. PHT was defined as estimated right ventricular systolic pressure >40 mm Hg. Multivariate logistic regression models were applied. Final study population included 25 916 patients with a median age of 59 (interquartile range, 44-69) years, of whom 12 501 (48%) were men and 13 265 (51%) had systemic arterial hypertension. Compared with normotensive patients, hypertensive patients were 3.2 times more likely to have PHT (95% CI, 2.91-3.53; P<0.001). A multivariate model adjusted for clinical and echocardiographic parameters that are known to be associated with PHT demonstrated that hypertensive patients are almost 3 times more likely to have PHT (95% CI, 2.45-3.15; P<0.001). The association was significant in multiple subgroups but was more significant among women compared with men (odds ratio, 3.1 versus 2.4; P for interaction <0.001). Conclusions PHT is associated with systemic arterial hypertension irrespective of left heart disease. The association is more pronounced among women.
引用
收藏
页数:23
相关论文
共 17 条
[1]   2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) [J].
Baumgartner, Helmut ;
Falk, Volkmar ;
Bax, Jeroen J. ;
De Bonis, Michele ;
Hamm, Christian ;
Holm, Per Johan ;
Iung, Bernard ;
Lancellotti, Patrizio ;
Lansac, Emmanuel ;
Rodriguez Munoz, Daniel ;
Rosenhek, Raphael ;
Sjogren, Johan ;
Tornos Mas, Pilar ;
Vahanian, Alec ;
Walther, Thomas ;
Wendler, Olaf ;
Windecker, Stephan ;
Luis Zamorano, Jose ;
Windecker, Stephan ;
Aboyans, Victor ;
Agewall, Stefan ;
Barbato, Emanuele ;
Bueno, Hector ;
Coca, Antonio ;
Collet, Jean-Philippe ;
Coman, Ioan Mircea ;
Dean, Veronica ;
Delgado, Victoria ;
Fitzsimons, Donna ;
Gaemperli, Oliver ;
Hindricks, Gerhard ;
Iung, Bernard ;
Juni, Peter ;
Katus, Hugo A. ;
Knuuti, Juhani ;
Lancellotti, Patrizio ;
Leclercq, Christophe ;
McDonagh, Theresa ;
Piepoli, Massimo Francesco ;
Ponikowski, Piotr ;
Richter, Dimitrios J. ;
Roffi, Marco ;
Shlyakhto, Evgeny ;
Simpson, Iain A. ;
Zamorano, Jose Luis ;
Kzhdryan, Hovhannes K. ;
Mascherbauer, Julia ;
Samadov, Fuad ;
Shumavets, Vadim ;
Van Camp, Guy .
EUROPEAN HEART JOURNAL, 2017, 38 (36) :2739-+
[2]   Worldwide Trends in Prevalence, Mortality, and Disability-Adjusted Life Years for Hypertensive Heart Disease From 1990 to 2017 [J].
Dai, Haijiang ;
Bragazzi, Nicola Luigi ;
Younis, Arwa ;
Zhong, Wen ;
Liu, Xinyao ;
Wu, Jianhong ;
Grossman, Ehud .
HYPERTENSION, 2021, 77 (04) :1223-1233
[3]   Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension [J].
Ferreira, Anderson J. ;
Shenoy, Vinayak ;
Yamazato, Yoriko ;
Sriramula, Srinivas ;
Francis, Joseph ;
Yuan, Lihui ;
Castellano, Ronald K. ;
Ostrov, David A. ;
Oh, Suk Paul ;
Katovich, Michael J. ;
Raizada, Mohan K. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (11) :1048-1054
[4]   LEFT-VENTRICULAR FILLING AND STRESS RESPONSE PATTERN IN ESSENTIAL-HYPERTENSION [J].
GROSSMAN, E ;
OREN, S ;
MESSERLI, FH .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (05) :502-506
[5]   Intrapulmonary Activation of the Angiotensin-Converting Enzyme Type 2/Angiotensin 1-7/G-Protein-Coupled Mas Receptor Axis Attenuates Pulmonary Hypertension in Ren-2 Transgenic Rats Exposed to Chronic Hypoxia [J].
Hampl, V. ;
Herget, J. ;
Bibova, J. ;
Banasova, A. ;
Huskova, Z. ;
Vanourkova, Z. ;
Jichova, S. ;
Kujal, P. ;
Vernerova, Z. ;
Sadowski, J. ;
Cervenka, L. .
PHYSIOLOGICAL RESEARCH, 2015, 64 (01) :25-38
[6]   PULMONARY ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) AND INFLAMMATORY LUNG DISEASE [J].
Jia, Hongpeng .
SHOCK, 2016, 46 (03) :239-248
[7]   Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats [J].
Kanno, S ;
Wu, YJL ;
Lee, PC ;
Billiar, TR ;
Ho, C .
CIRCULATION, 2001, 104 (08) :945-950
[8]   Recommendations for chamber quantification [J].
Lang, Roberto M. ;
Bierig, Michelle ;
Devereux, Richard B. ;
Flachskampf, Frank A. ;
Foster, Elyse ;
Pellikka, Patricia A. ;
Picard, Michael H. ;
Roman, Mary J. ;
Seward, James ;
Shanewise, Jack ;
Solomon, Scott ;
Spencer, Kirk T. ;
Sutton, Martin St. John ;
Stewart, William .
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2006, 7 (02) :79-108
[9]  
Larry Jameson J., 2018, HARRISONS PRINCIPLES, V1, P4048
[10]   Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-κB Pathway [J].
Meng, Ying ;
Yu, Chang-Hui ;
Li, Wei ;
Li, Ting ;
Luo, Wei ;
Huang, Shan ;
Wu, Ping-Sheng ;
Cai, Shao-Xi ;
Li, Xu .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2014, 50 (04) :723-736